Further evidence suggests that the feasibility of encoding the PD-L1 blocking antibody and IL-12p70 (CAd12_PDL1) combined with HER2-CAR-T cells infusion in HNSCC xenograft and orthotopic models. This evidence concerns the gene ERBB2 and head and neck squamous cell carcinoma.